Gosset Ownership
Private
Therapeutic Areas
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Wave Neuroscience General Information
Wave Neuroscience’s MeRT® technology is FDA-cleared for certain uses, with over 30,000 patients treated. The company reports significant improvements in symptoms of PTSD, TBI, depression, anxiety, and other neurological conditions based on real-world outcomes from its Braincare™ platform. No formal published pivotal clinical trial data was cited in the search results.
Contact Information
Website
Primary Industry
Therapeutic Medical Devices
Corporate Office
Newport Beach, California
USA
USA
Drug Pipeline
No pipeline data available
Key Partnerships
Collective Health
Wave Neuroscience Funding
No funding data available
To view Wave Neuroscience's complete valuation and funding history, request access »